Dr. Janessa Laskin is a clinical associate professor in the Department of Medicine at the University of British Columbia, associate member in Canada’s Michael Smith Genome Sciences Centre, and has been an active member of the medical oncology staff at BC Cancer since 2003.
Dr. Laskin’s clinical and research interests have primarily focused around lung and head and neck cancers, and in recent years, her research has evolved towards genomic and personalized medicine.
Dr. Laskin is the co-founder and clinical leader of the Personalized OncoGenomics (POG) program, a translational research effort that uses in-depth genomic sequencing to guide chemotherapy decision-making in a clinically relevant time-frame.
For an up-to-date list of publications by Dr. Laskin, please see ResearchGate.